SCHEMBL28907783

SCHEMBL28907783

CC(=O)On1c(C(C)(C)C)cc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC10 Q969S8 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
MCL1 Q07820 1/20 0.38
NOTUM Q6P988 1/20 0.37
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
DAO P14920 2/20 0.36
MAPK14 Q16539 2/20 0.36
TP53 P04637 2/20 0.35
NR1H2 P55055 2/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
TSHR P16473 1/20 0.34
CNR2 P34972 1/20 0.33
SLC9A1 P19634 1/20 0.33
AHR P35869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28853394 0.79 DAO (0.41) MCL1NOTUMKDM4EALDH1A1HPGD
SCHEMBL5201509 0.79 TP53 (0.47) HDAC6MCL1NOTUMKDM4EALDH1A1
SCHEMBL6471856 0.76 MCL1 (0.39) MCL1NOTUMKDM4EALDH1A1HPGD
SCHEMBL5227447 0.75 ALDH1A1 (0.56) MCL1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL28007095 0.72 HDAC10 (0.46) HDAC10HDAC6MCL1KDM4EALDH1A1
SCHEMBL9496147 0.72 CA12 (0.50) MCL1NOTUMKDM4EALDH1A1HPGD
SCHEMBL29103886 0.72 CHRM2 (0.34) HDAC10HDAC6ALDH1A1
SCHEMBL9849390 0.72 IRAK4 (0.44) MCL1NOTUMKDM4EALDH1A1HPGD
SCHEMBL18346854 0.71 ALDH1A1 (0.49) MCL1NOTUMKDM4EALDH1A1HPGD
SCHEMBL12922870 0.71 NR1H2 (0.56) NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105816453-B Substituted tricyclic acid derivatives as S1P1 receptor agonists for the treatment of autoimmune and inflammatory disorders 艾尼纳制药公司 2021-03-05 CN disclosed